Skip to main content

ADVERTISEMENT

value-based care

Hinkes
Blog
01/28/2021
In many countries, there is a single payer system, in which the government pays the cost of health care and the providers are on salary. In this model, there is no billing as providers merely provide the services mandated by the government...
In many countries, there is a single payer system, in which the government pays the cost of health care and the providers are on salary. In this model, there is no billing as providers merely provide the services mandated by the government...
In many countries, there is a...
01/28/2021
Podiatry Today
Perspectives
11/18/2020
Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders­—clinically and...
Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders­—clinically and...
...
11/18/2020
Journal of Clinical Pathways
News
08/18/2020
Among patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT), hospital length of stay is a driver for increased cost and can be predicted using patient- and transplant-related characteristics,...
Among patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT), hospital length of stay is a driver for increased cost and can be predicted using patient- and transplant-related characteristics,...
Among...
08/18/2020
Journal of Clinical Pathways
News
08/13/2020
In the first year, cancer centers that implement payment models with shared-savings components can be associated with fewer visits and lower costs, however these savings are largely offset by the cost of program...
In the first year, cancer centers that implement payment models with shared-savings components can be associated with fewer visits and lower costs, however these savings are largely offset by the cost of program...
In the...
08/13/2020
Journal of Clinical Pathways
News
08/07/2020
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...
...
08/07/2020
Journal of Clinical Pathways
MD Anderson, Philips Collaborate to Offer Personalized Care on a Global Scale
Interview
07/14/2020
In June 2020, The University of Texas MD Anderson Cancer Center and Royal Philips announced a collaboration to provide oncologists with biomarker-driven, evidence-based therapy and clinical trial guidance through...
In June 2020, The University of Texas MD Anderson Cancer Center and Royal Philips announced a collaboration to provide oncologists with biomarker-driven, evidence-based therapy and clinical trial guidance through...
In...
07/14/2020
Journal of Clinical Pathways
Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward
Interview
07/07/2020
In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...
In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...
In...
07/07/2020
Journal of Clinical Pathways
News
06/25/2020
In June 2020, the American Society of Clinical Oncology (ASCO) launched the SmartLinQ Quality Oncology Practice Initiative (QOPI) Certification Pathway for practices participating in the QOPI Certification...
In June 2020, the American Society of Clinical Oncology (ASCO) launched the SmartLinQ Quality Oncology Practice Initiative (QOPI) Certification Pathway for practices participating in the QOPI Certification...
In...
06/25/2020
Journal of Clinical Pathways
Beyond Face Value: Why Indirect Benefits of Cancer Care Matter
Quality Outlook
05/27/2020
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.
Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.
Tom Valuck, MD, JD, and...
05/27/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways